近日，深圳市瑞图生物技术有限公司宣布成功完成超亿元B2轮融资。本轮融资由国科投资、国内知名基金领投，深投控资本参与投资，点石资本担任独家财务顾问。该公司专注于人工智能与医学诊断的深度融合，为医疗行业提供了高效准确的诊断方案。此次融资将主要用于继续研发创新技术，提升产品性能，并拓展市场渠道，助力瑞图生物在AI生物医学领域的领先地位。
新闻翻译：
Recently, Shenzhen Ruitu Biotechnology Co., Ltd. announced the successful completion of a超过 100 million yuan B2 round of financing. This round of financing was led by Guokai Investment and a domestic well-known fund, with Shenzhen Daiucheng Capital participating in investment, and Dianxi Capital serving as the exclusive financial advisor. The company focuses on the deep integration of artificial intelligence and medical diagnosis, providing efficient and accurate diagnosis solutions for the medical industry. The financing will be used to further develop innovative technologies, improve product performance, and expand market channels,助力 the company’s leading position in the field of AI-based biomedical technology.
【来源】https://www.vbdata.cn/1518942969
Views: 2